## Abstract ## Purpose To investigate the feasibility of combined dynamic contrast enhanced (DCE) and magnetic resonance spectroscopy (MRS) in evaluating breast lesions. ## Methods Nine patients with positive mammograms scheduled for either biopsy or mastectomy were examined on a 1.5‐T MR scanne
Combined quantitative dynamic contrast-enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer
✍ Scribed by Ferdinand A. van Dorsten; Marinette van der Graaf; Marc R.W. Engelbrecht; Geert J.L.H. van Leenders; Albert Verhofstad; Mark Rijpkema; Jean J.M.C.H. de la Rosette; Jelle O. Barentsz; Arend Heerschap
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 418 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Purpose:
To differentiate prostate carcinoma from healthy peripheral zone and central gland using quantitative dynamic contrast-enhanced (dce) magnetic resonance (mr) imaging and two-dimensional (1)h mr spectroscopic imaging (mrsi) combined into one clinical protocol.
Materials and methods:
Twenty-three prostate cancer patients were studied with a combined dce-mri and mrsi protocol. cancer regions were localized by histopathology of whole mount sections after radical prostatectomy. pharmacokinetic modeling parameters, k(trans) and k(ep), as well as the relative levels of the prostate metabolites citrate, choline, and creatine, were determined in cancer, healthy peripheral zone (pz), and in central gland (cg).
Results:
K(trans) and k(ep) were higher (p < 0.05) in cancer and in cg than in normal pz. the (choline + creatine)/citrate ratio was elevated in cancer compared to the pz and cg (p < 0.05). while a (choline + creatine)/citrate ratio above 0.68 was found to be a reliable indicator of cancer, elevated k(trans) was only a reliable cancer indicator in the diagnosis of individual patients. k(trans) and (choline + creatine)/citrate ratios in cancer were poorly correlated (pearson r(2) = 0.07), and thus microvascular and metabolic abnormalities may have complementary value in cancer diagnosis.
Conclusion:
The combination of high-resolution spatio-vascular information from dynamic mri and metabolic information from mrsi has excellent potential for improved localization and characterization of prostate cancer in a clinical setting. j. magn. reson. imaging 2004;20:279-287.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the diagnostic accuracy of a combination of dynamic contrast‐enhanced MR imaging (DCE‐MRI) and diffusion‐weighted MR imaging (DWI) in characterization of enhanced mass on breast MR imaging and to find the strongest discriminators between carcinoma and benignancy.
## Abstract ## Purpose To characterize rounded atelectasis (RA) with dynamic contrast‐enhanced MRI in the differential diagnosis of solitary peripheral pulmonary neoplasm. ## Materials and Methods Twenty‐four patients with diagnostically equivocal peripheral pulmonary nodules were examined with
## Abstract ## Purpose: To determine the reproducibility of 3D proton magnetic resonance spectroscopic imaging (^1^H‐MRSI) of the human prostate in a multicenter setting at 1.5T. ## Materials and Methods: Fourteen subjects were measured twice with 3D point‐resolved spectroscopy (PRESS) ^1^H‐MRSI